27613-35-0

Basic information

• Product Name: Benzonitrile, 4-formyl-2-methyl- (9CI)
• Synonyms: Benzonitrile, 4-formyl-2-methyl- (9CI);4-forMyl-2-Methyl-benzonitrile;4-cyano-3-methylbenzaldehyde
• CAS NO: 27613-35-0
• Molecular Formula: C₉H₇NO
• Molecular Weight: 145.15798
• Product Categories: ALDEHYDE
• Mol File: 27613-35-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzonitrile, 4-formyl-2-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-formyl-2-methyl- (9CI)(27613-35-0)
• EPA Substance Registry System: Benzonitrile, 4-formyl-2-methyl- (9CI)(27613-35-0)

Safety Data

• Hazardous Substances Data: 27613-35-0(Hazardous Substances Data)

Usage

General Description

Benzonitrile, 4-formyl-2-methyl- (9CI) is a chemical compound with the molecular formula C9H7NO. It is a derivative of benzonitrile, with a formyl group and a methyl substituent at the 2 and 4 positions, respectively. Benzonitrile, 4-formyl-2-methyl- (9CI) is commonly used in organic synthesis as a reagent for the production of various pharmaceuticals and fine chemicals. It is also used as a building block for the synthesis of heterocyclic compounds and as a starting material for the preparation of aromatic aldehydes and acids. Benzonitrile, 4-formyl-2-methyl- (9CI) is classified as a hazardous chemical and should be handled and stored with appropriate safety precautions.

Upstream product

• 67832-11-5 4-bromo-2-methylbenzonitrile 
• 68-12-2 N,N-dimethyl-formamide 
• 557-21-1 zinc(II) cyanide 

Downstream Products

• 864731-61-3 A₁₄₄₃ 

Relevant articles and documents

Fluorine thramine intermediate and method for preparing flumbine by using same

The invention discloses a fluororesonide intermediate and a method for preparing the same, and a fluororesonide intermediate -5. Routes include the use of m-xylene as starting materials, halogenation. Oxidation reaction The intermediate -5 is further obtained by hydroximation, cyanolation, hydrolysis reaction or cyanation, oximation, and hydrolysis reaction. As some examples of the present invention, synthetic routes were increased 2 steps from 5 steps in the prior art, but surprisingly high overall yields were obtained and the purity of intermediate -5 was significantly increased. , The starting material of the intermediate -5 is prepared from high 4 - bromo -2 - methylbenzoic acid to low-priced m-xylene, so that the cost of the intermediate -5 is greatly reduced. , The reaction condition is mild, the synthesis difficulty is low, and the environment is more environmentally friendly.

Amine Compounds

There is provided a compound exhibiting an activity of suppressing immune response with reduced adverse drug reactions, which compound is useful in the chemotherapy for preventing or treating, for example, a wide range of various autoimmune diseases including systemic erythematodes, chronic rheumatoid arthritis, Type I diabetes, inflammatory bowel disease, biliary cirrhosis, uveitis, multiple sclerosis or other disorders, or chronic inflammatory diseases, or cancers, lymphoma or leukemia, or resistance to organ or tissue transplantation or rejection against transplantation. Novel amine compounds having an S1P1/Edg1 receptor agonist effect, possible stereoisomers or racemic bodies of the compounds, or pharmacologically acceptable salts, hydrates or solvates of the compound, the stereoisomers or the racemic bodies, or prodrugs of the compounds, the stereoisomers, the racemic bodies, the salts, the hydrates or the solvates, are provided.